Learn practical guidance and actionable insight for addressing the complexity of study start-up and execution outside the traditional cell and gene therapy sites.
TORONTO (PRWEB)
May 11, 2023
Thanks to scientific advances and resource investment, the cell and gene therapy pipeline continues to expand. Current research infrastructure, however, cannot support the increased clinical development. The use of exploratory endpoints is growing, and often, small patient populations are difficult to identify, alongside challenges with recruiting diverse patient populations. Meanwhile, sites are understaffed and overwhelmed.
To support sponsors and their partners to innovate in this growing, but uncertain space Parexel presents New Medicines, Novel Insights which is their perspective on speeding life-changing medicines to market. With a focus on cell and gene therapies, the second report in the series launches in mid-May and explores factors that are critical to therapy development success, accounting for the market and operational landscape in 2023.
In this webinar, the speakers explore one of the topical clinical development perspectives contained within the report, the challenges and opportunities of moving trials into the community. Learn practical guidance and actionable insight for addressing the complexity of study start-up and execution outside the traditional cell and gene therapy sites.
Join this webinar to learn how moving cell and gene therapy trials from overloaded research centers to communities can increase diversity, expand patient access and relieve site fatigue. Hear perspectives from Parexel’s site and project leadership experts, and Chris Jenkins from Clinical Biosafety Services, all working together to expand into community-based settings.
Join Alberto Grignolo (Moderator), PhD, Corporate Vice President, Corporate Strategy & Thought Leadership, Parexel; Chris Jenkins, PhD, MPH, Principal Partner & Chief Gene Therapy Biosafety Officer, Clinical Biosafety Services; Kathy Scott, Associate Director, Site Alliances, Parexel; and Shannon Macquarrie, Senior Vice President, Project Leadership, Parexel, for the live webinar on Thursday, June 1, 2023, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Moving Cell and Gene Therapy Trials into the Community: Challenges and Opportunities.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com
Share article on social media or email: